Clinical Trials on Allergic Rhinitis Due to Pollen in Belgium

Total 38 results

Hippocreates

Completed

Validation and Reproducibility of S.P.A.T. With Allergens

Allergy Pollen | Allergy to House Dust

Belgium
Regeneron Pharmaceuticals

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REGN5713-5714-5715 in Healthy Adult Participants

Healthy Volunteers | Birch Pollen Allergy

Belgium
Biomay AG

Completed

Phase II Study of Grass Pollen Allergy Vaccine BM32

Grass Pollen Allergy

Austria, Belgium, Denmark, Germany, Netherlands, Slovenia
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Hay Fever | Grass Pollen Allergy

Belgium, France, Luxembourg
Labo'Life

Completed

Efficacy of 2LALERG (Homeopathic Drug) in Allergic Rhinitis Related to Grass Pollen (LLB-2016-01)

Seasonal Allergy

Belgium
Regeneron Pharmaceuticals

Terminated

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Allergic Rhinitis Due to Cat Allergy

United States, Belgium, Germany, Poland, Canada, France
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis

Chronic Rhinosinusitis With Nasal Polyps | Hyperactivity | Allergic Rhinitis Due to House Dust Mite

Belgium
Universitaire Ziekenhuizen KU Leuven
AZ Sint-Jan AV

Recruiting

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis | Local Allergic Rhinitis

Belgium
Universitaire Ziekenhuizen KU Leuven

Terminated

Role of the Central Nervous System in Allergic Rhinitis

House Dust Mite Allergy

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)

Allergic Rhinitis | House Dust Mite Allergy

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients

Allergic Rhinitis

Belgium
University Hospital, Ghent
Bekaert textiles NV Waregem

Completed

House Dust Mite Allergen Reduction in Bedding: Purotex Impregnated Covers of Bekaert Textiles (Purotex covers)

Allergic Rhinitis

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy

Allergic Rhinitis

Belgium
BioTech Tools S.A.

Completed

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Hay Fever

Belgium
GlaxoSmithKline

Completed

Long Term Safety Of GW685698X Via Nasal Biopsy

Rhinitis, Allergic, Perennial

Netherlands, Belgium
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever

Spain, Belgium, Italy
Universitaire Ziekenhuizen KU Leuven
Regeneron Pharmaceuticals

Recruiting

Basal Instincts: Towards Better Understanding of Basal Cell Function in Chronic Rhinosinusitis With Nasal Polyps

Allergic Rhinitis | Chronic Rhinosinusitis With Nasal Polyps

Belgium
Regeneron Pharmaceuticals

Completed

Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis

Conjunctivitis | Allergic Rhinitis

United States, Belgium, Canada, Denmark, Germany
HAL Allergy

Completed

PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Belgium, Germany, Austria, Netherlands, Spain
HAL Allergy

Completed

Twin SUBLIVAC® Grasses Clinical Efficacy Study

Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

Germany, Poland, Belgium, Netherlands
GlaxoSmithKline

Completed

Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.

Streptococcus Agalactiae | Bacterial Infection Due to Streptococcus, Group B

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis

Non-allergic Rhinitis

Belgium
Euro Tissue Bank
Dutch Burns Foundation

Terminated

Glyaderm Clinical Evaluation Multicenter Study

Full-thickness Skin Loss Due to Burn, Unspecified Site

Spain, Netherlands, Belgium, Greece
Hasselt University
Jessa Hospital

Unknown

Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events

Incidence of Readmissions | ADE's Due to Anticoagulants

Belgium
HAL Allergy

Completed

SUBLIVAC FIX Birch Phase III Short-term Efficacy

Birch Pollen Induced Rhinitis/Rhinoconjunctivitis

Belgium, Germany, Czech Republic, Poland, Slovakia
Aridis Pharmaceuticals, Inc.

Completed

Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)

Pneumonia Due to Staphylococcus Aureus

United States, Belgium, France, Spain
Virometix
Center of Vaccinology, Ghent, Belgium (CEVAC); Expert Clinical Services Organization...

Completed

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Acute Bronchiolitis Due to Respiratory Syncytial Virus

Belgium
Fresenius Kabi
B. Braun Melsungen AG; European Society of Anaesthesiology and Intensive Care

Completed

Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients (TETHYS)

Hypovolemia Due to Acute Blood Loss

Germany, Spain, France, Czechia, South Africa, Belgium, Netherlands
Fresenius Kabi
B. Braun Melsungen AG; European Society of Anaesthesiology and Intensive Care

Completed

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery (PHOENICS)

Hypovolaemia Due to Acute Blood Loss

Spain, France, Netherlands, Germany, Poland, Belgium, Czechia, Croatia, Austria, Romania
Novartis Vaccines

Completed

Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects

Influenza | Seasonal Influenza | Human Influenza | Influenza Due to Unspecified Influenza Virus

Belgium
University Ghent

Completed

Effectiveness of Speech Therapy in Trans Women.

Gender Dysphoria | Speech Therapy | Transgenderism | Voice Disorder Due to Transsexualism

Belgium
University Ghent
3M

Terminated

Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly

Pressure Ulcer | Diaper Rash | Incontinence-associated Dermatitis | Irritant Contact Dermatitis Due to Incontinence

Belgium
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney Injury

Acute Kidney Injury Due to Sepsis

Hungary, Belgium, Germany, France, Spain
Astellas Pharma Inc

Completed

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch (LIFT)

or Peripheral Nerve Injury (PNI) | Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN)

Belgium, Czechia, Denmark, Ireland, Norway, Slovakia, United Kingdom
Gilead Sciences

Terminated

Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)

Liver Fibrosis Due to NASH

United States, Spain, France, Canada, Germany, Italy, Puerto Rico, United Kingdom, Belgium
Biogen

Recruiting

A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age (CELIA)

Mild Cognitive Impairment Due to Alzheimer's Disease | Alzheimer's Disease Dementia

Belgium, United States, Australia, Italy, Spain, Denmark, United Kingdom, Czechia, France, Poland, Switzerland, Germany, Canada, Japan, Finland, Netherlands, Sweden
AM-Pharma

Terminated

(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI

Acute Kidney Injury Due to Sepsis

Belgium, Spain, United States, Austria, Denmark, France, United Kingdom, Finland, New Zealand, Australia, Germany, Canada, Netherlands, Ireland, Japan
Merz Pharmaceuticals GmbH

Recruiting

Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury (PATTERN)

Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury

United States, Belgium, Czechia, France, Germany, Italy, Poland, Spain, Switzerland, United Kingdom, Australia, Hungary, Norway, Slovakia, Ukraine, Russian Federation

Clinical Trials on Allergic Rhinitis Due to Pollen in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations